ZA200307474B - CCR5 antagonists useful for treating AIDS. - Google Patents

CCR5 antagonists useful for treating AIDS. Download PDF

Info

Publication number
ZA200307474B
ZA200307474B ZA200307474A ZA200307474A ZA200307474B ZA 200307474 B ZA200307474 B ZA 200307474B ZA 200307474 A ZA200307474 A ZA 200307474A ZA 200307474 A ZA200307474 A ZA 200307474A ZA 200307474 B ZA200307474 B ZA 200307474B
Authority
ZA
South Africa
Prior art keywords
alkyl
compound
composition
treatment
substance
Prior art date
Application number
ZA200307474A
Other languages
English (en)
Inventor
Michael W Miller
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200307474B publication Critical patent/ZA200307474B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA200307474A 2001-03-29 2003-09-25 CCR5 antagonists useful for treating AIDS. ZA200307474B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27993801P 2001-03-29 2001-03-29

Publications (1)

Publication Number Publication Date
ZA200307474B true ZA200307474B (en) 2004-12-24

Family

ID=23070981

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200307474A ZA200307474B (en) 2001-03-29 2003-09-25 CCR5 antagonists useful for treating AIDS.

Country Status (30)

Country Link
US (5) US6720325B2 (fr)
EP (2) EP1591444B1 (fr)
JP (2) JP4248251B2 (fr)
KR (1) KR100613528B1 (fr)
CN (1) CN100519554C (fr)
AR (1) AR033452A1 (fr)
AT (2) ATE466009T1 (fr)
AU (1) AU2002255947B8 (fr)
BR (1) BR0208398A (fr)
CA (1) CA2442227C (fr)
CZ (1) CZ20032636A3 (fr)
DE (2) DE60236218D1 (fr)
DK (1) DK1373256T3 (fr)
ES (2) ES2342942T3 (fr)
HK (2) HK1057363A1 (fr)
HU (1) HUP0400349A3 (fr)
IL (1) IL157551A0 (fr)
MX (1) MXPA03008853A (fr)
MY (1) MY128609A (fr)
NO (1) NO326349B1 (fr)
NZ (1) NZ527768A (fr)
PE (1) PE20020996A1 (fr)
PL (1) PL364560A1 (fr)
PT (1) PT1373256E (fr)
RU (1) RU2316553C2 (fr)
SI (1) SI1373256T1 (fr)
SK (1) SK287521B6 (fr)
TW (1) TWI237638B (fr)
WO (1) WO2002079194A1 (fr)
ZA (1) ZA200307474B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1591444B1 (fr) * 2001-03-29 2010-04-28 Schering Corporation Antagonistes de la CCR5 utilisés pour la traitement de la CIDA.
WO2003004487A1 (fr) 2001-07-02 2003-01-16 Astrazeneca Ab Derives de piperidine convenant comme modulateurs de l'activite du recepteur de la chimiokine
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
US7132539B2 (en) 2002-10-23 2006-11-07 The Procter & Gamble Company Melanocortin receptor ligands
US7452992B2 (en) 2002-12-13 2008-11-18 Smithkline Beecham Corporation Heterocyclic compounds as CCR5 antagonists
PE20040769A1 (es) * 2002-12-18 2004-11-06 Schering Corp Derivados de piperidina utiles como antagonisas ccr5
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
JP4757802B2 (ja) * 2003-11-03 2011-08-24 シェーリング コーポレイション ケモカインレセプターの阻害剤として有用なビピペリジニル誘導体
JP2007520556A (ja) * 2004-02-05 2007-07-26 シェーリング コーポレイション Ccr3アンタゴニストとして有用なピペリジン誘導体
SE0400925D0 (sv) * 2004-04-06 2004-04-06 Astrazeneca Ab Chemical compounds
NZ550370A (en) * 2004-04-13 2009-09-25 Incyte Corp Piperazinylpiperidine derivatives as chemokine receptor antagonists
RU2409565C2 (ru) 2004-09-13 2011-01-20 Оно Фармасьютикал Ко., Лтд. Азотистые гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
WO2006071875A1 (fr) 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Composes utilises comme antagonistes des recepteurs de la chemokine
US7635698B2 (en) 2004-12-29 2009-12-22 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
CA2594114A1 (fr) * 2005-01-06 2006-07-13 Schering Corporation Synthese d'antagonistes des recepteurs ccr5
EP1836190A2 (fr) * 2005-01-06 2007-09-26 Schering Corporation Preparation de sels pharmaceutiques de composes piperazine
AR055313A1 (es) 2005-02-23 2007-08-15 Schering Corp Derivados piperidinil piperidina utiles como inhibidores de receptores de quimioquinas. proceso de obtencion y composiciones farmaceuticas
EP1858887A1 (fr) * 2005-02-23 2007-11-28 Schering Corporation Dérivés de pipéridine pipéridinyle servant d inhibiteurs de récepteurs chémokines
KR20080037655A (ko) 2005-07-21 2008-04-30 아스트라제네카 아베 신규 피페리딘 유도체
US7462485B2 (en) * 2005-10-07 2008-12-09 Glaser Lawrence F Modified erythrocytes and uses thereof
TW200745087A (en) * 2006-02-24 2007-12-16 Schering Corp CCR5 antagonists useful for treating HIV
US20080108586A1 (en) * 2006-09-06 2008-05-08 Incyte Corporation Combination therapy for human immunodeficiency virus infection
MX2009006881A (es) * 2006-12-22 2009-07-03 Schering Corp Procesos para la preparacion de antagonistas del receptor ccr-5 utilizando compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido.
EP2259772A2 (fr) * 2008-02-29 2010-12-15 Schering Corporation Antagonistes de ccr5 en tant que produits prophylactiques pour prévenir une infection par le vih et procédés d'inhibition de la transmission de celle-ci
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368854A (en) 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
AU6135294A (en) 1993-02-12 1994-08-29 Merck & Co., Inc. Piperazine derivatives as hiv protease inhibitors
US5889006A (en) 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
DE69629961T2 (de) 1995-06-07 2004-07-22 Kimberly-Clark Worldwide, Inc., Neenah Inhibierung von Exoproteinen in absorbiereden Produkten
NZ321575A (en) 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
TW531537B (en) 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
US5952349A (en) 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
US5977138A (en) 1996-08-15 1999-11-02 Schering Corporation Ether muscarinic antagonists
EP1003514A4 (fr) 1997-07-25 2000-10-11 Merck & Co Inc Amines cycliques modulant l'activite des recepteurs de chimiokines
US6066636A (en) 1998-06-30 2000-05-23 Schering Corporation Muscarinic antagonists
EP1013276A1 (fr) * 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalcanes comme modulateurs de CCR5
WO2000066559A1 (fr) 1999-05-04 2000-11-09 Schering Corporation Derives de piperidine faisant office d'antagonistes ccr5
SK286641B6 (sk) * 1999-05-04 2009-03-05 Schering Corporation Piperazínové deriváty užitočné ako CCR5 antagonisty, farmaceutické prípravky s ich obsahom a ich použitie
EP1591444B1 (fr) * 2001-03-29 2010-04-28 Schering Corporation Antagonistes de la CCR5 utilisés pour la traitement de la CIDA.

Also Published As

Publication number Publication date
DE60236218D1 (de) 2010-06-10
DK1373256T3 (da) 2005-10-10
CZ20032636A3 (cs) 2003-12-17
DE60204951T2 (de) 2006-05-11
PT1373256E (pt) 2005-11-30
ATE299139T1 (de) 2005-07-15
AU2002255947B2 (en) 2005-10-27
CN1547580A (zh) 2004-11-17
NO20034311L (no) 2003-11-26
HUP0400349A3 (en) 2010-03-29
BR0208398A (pt) 2004-06-15
US6720325B2 (en) 2004-04-13
JP2004525157A (ja) 2004-08-19
JP4248251B2 (ja) 2009-04-02
MY128609A (en) 2007-02-28
SK287521B6 (sk) 2010-12-07
MXPA03008853A (es) 2003-12-04
KR20030083014A (ko) 2003-10-23
EP1591444B1 (fr) 2010-04-28
DE60204951D1 (de) 2005-08-11
IL157551A0 (en) 2004-03-28
US20050059666A1 (en) 2005-03-17
WO2002079194A1 (fr) 2002-10-10
CA2442227C (fr) 2008-10-28
NO326349B1 (no) 2008-11-17
RU2003131879A (ru) 2005-05-10
SK11962003A3 (sk) 2004-03-02
US20060063771A1 (en) 2006-03-23
US7060701B2 (en) 2006-06-13
EP1373256B1 (fr) 2005-07-06
HK1057363A1 (en) 2004-04-02
CA2442227A1 (fr) 2002-10-10
US20040157854A1 (en) 2004-08-12
US7098213B2 (en) 2006-08-29
US20030008877A1 (en) 2003-01-09
EP1373256A1 (fr) 2004-01-02
AR033452A1 (es) 2003-12-17
HUP0400349A2 (hu) 2004-12-28
TWI237638B (en) 2005-08-11
PL364560A1 (en) 2004-12-13
CN100519554C (zh) 2009-07-29
NZ527768A (en) 2005-03-24
US7008946B2 (en) 2006-03-07
ES2342942T3 (es) 2010-07-19
ATE466009T1 (de) 2010-05-15
ES2242856T3 (es) 2005-11-16
SI1373256T1 (sl) 2005-12-31
US20050143390A1 (en) 2005-06-30
JP2008074862A (ja) 2008-04-03
RU2316553C2 (ru) 2008-02-10
US6900211B2 (en) 2005-05-31
PE20020996A1 (es) 2002-11-01
EP1591444A1 (fr) 2005-11-02
HK1083505A1 (en) 2006-07-07
NO20034311D0 (no) 2003-09-26
AU2002255947B8 (en) 2005-11-17
KR100613528B1 (ko) 2006-08-16

Similar Documents

Publication Publication Date Title
ZA200307474B (en) CCR5 antagonists useful for treating AIDS.
EP1421075B1 (fr) Derives de la piperidine utilises comme antagonistes du ccr5 pour le traitement du sida
ES2238277T3 (es) Terapia anti-vih con una combinacion de un interferon alfa-pegilado y un antagonista de ccr5.
AU2002255947A1 (en) CCR5 antagonists useful for treating AIDS
US20070123538A1 (en) Compositions comprising a combination of CCR5 and CXCR4 antagonists
ZA200504772B (en) Piperidine derivatives useful as CCR5 antagonists
JP4303969B2 (ja) Ccr5アンタゴニストとして有用なアリールオキシム−ピペラジン
WO2002056902A2 (fr) Procede de combinaison permettant de traiter des infections virales
US20070203149A1 (en) Ccr5 antagonists useful for treating hiv
MX2008007042A (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
AU2002245148A1 (en) CCR5 antagonist and DP-178 polypeptide for treating viral infections